“…Nonetheless, the driving mechanisms of the hypothalamic functions are far to be completely understood, and even though there is evidence that hypothalamic activity is deeply influenced by the serotonergic tone [Chalmers et al, 1988;Reichlin, 1988;Minson et al, 1990;Recio et al, 1996;Schuhler et al, 1999;Lowry, 2002;Serretti et al, 2004; Aisa et al, 2007;Marcos et al, 2008], and the efficacy of antidepressant drugs with a serotonergic activity in severe forms of depressive episodes has been widely demonstrated, it is reasonable to assess that serotonin receptors activated probably witness a first step event, whilst the antidepressant effect, or the depressive molecular mechanism itself, probably lies elsewhere within the molecular changes that follow the serotonergic activations. For example, it has been proposed that cannabinoid receptor 1 in hypothalamus and hippocampus may be the pivotal actor of the antidepressant properties of desipramine [Hill et al, 2006], but many other evidence based hypotheses involving diverse systems have been put forward as well [Alvarez and Banzan, 1992;Schlenker, 1998;Holsboer, 1999;Carrasco et al, 2004;Huang et al, 2004;Malkesman et al, 2007]. Further research in this field is mandatory before a complete depict is achieved.…”